Integrin α(IIb)β3 signaling in platelet adhesion and aggregation

Current Opinion in Cell Biology

Volumn 11, Issue 5, 1999, Pages 597-601

  Parise, Leslie V ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; INTEGRIN; PROTEIN KINASE; THROMBIN; THROMBOSPONDIN;

PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION;

EID: 0032820710     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(99)00018-6     Document Type: Review

References (51)

1. Vu TK, Hung DT, Wheaton VI, Coughlin SR Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 64:1991;1057-1068.
2. Hung DT, Vu TK, Wheaton VI, Ishii K, Coughlin SR Cloned platelet thrombin receptor is necessary for thrombin-induced platelet activation. J Clin Invest. 89:1992;1350-1353.
3. Furman MI, Liu L, Benoit SE, Becker RC, Barnard MR, Michelson AD The cleaved peptide of the thrombin receptor is a strong platelet agonist. Proc Natl Acad Sci USA. 95:1998;3082-3087.
4. Connolly AJ, Ishihara H, Kahn ML, Farese RV Jr., Coughlin SR Role of the thrombin receptor in development and evidence for a second receptor. Nature. 381:1996;516-519.
5. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, Coughlin SR Protease-activated receptor 3 is a second thrombin receptor in humans. Nature. 386:1997;502-506.
6. Kahn ML, Zheng YW, Huang W, Bigornia V, Zeng D, Moff S, Farese RV.Jr., Tam C, Coughlin SR A dual thrombin receptor system for platelet activation. Nature. 394:1998;690-694. In this landmark study, not only is the par-3 knockout mouse described but the sequence of par-4 is reported. The importance of PAR-3 and PAR-4 on murine platelets and PAR-4 on human platelets is delineated.
7. Kahn ML, Nakanishi-Matsui M, Shapiro MJ, Ishihara H, Coughlin SR Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin. J Clin Invest. 103:1999;879-887. Experiments in this study confirm that together PAR-1 and PAR-4 account for most thrombin signaling in human platelets.
8. Ishihara H, Zeng D, Connolly AJ, Tam C, Coughlin SR Antibodies to protease-activated receptor 3 inhibit activation of mouse platelets by thrombin. Blood. 91:1998;4152-4157.
9. 3. J Biol Chem. 272:1997;14740-14746.
10. Dorahy DJ, Thorne RF, Fecondo JV, Burns GF Stimulation of platelet activation and aggregation by a carboxy-terminal peptide from thrombospondin binding to the integrin-associated protein receptor. J Biol Chem. 272:1997;1323-1330.
11. Gao AG, Lindberg FP, Finn MB, Blystone SD, Brown EJ, Frazier WA Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin. J Biol Chem. 271:1996;21-24.
12. 3-dependent ligand binding. J Cell Biol. 123:1993;485-496.
13. 1 integrin in vascular smooth muscle cells. Mol Biol Cell. 9:1998;865-874.
14. Frazier WA, Gao AG, Dimitry J, Chung J, Brown EJ, Lindberg FP, Linder ME The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi. J Biol Chem. 274:1999;8554-8560. The direct physical and functional coupling of a five-transmembrane-spanning protein to the heterotrimeric G protein, Gi is described. This is significant for understanding the mechanism by which thrombospondin stimulates cells and because heterotrimeric G-proteins are most often coupled to seven-transmembrane-spanning proteins.
15. Ichinohe T, Takayama H, Ezumi Y, Arai M, Yamamoto N, Takahashi H, Okuma M Collagen-stimulated activation of Syk but not c-Src is severely compromised in human platelets lacking membrane glycoprotein VI. J Biol Chem. 272:1997;63-68.
16. Kehrel B, Wierwille S, Clemetson KJ, Anders O, Steiner M, Knight CG, Farndale RW, Okuma M, Barnes MJ Glycoprotein VI is a major collagen receptor for platelet activation: it recognizes the platelet-activating quaternary structure of collagen, whereas CD36, glycoprotein IIb/IIIa, and von Willebrand factor do not. Blood. 91:1998;491-499.
17. 1 integrin is a necessary co-receptor for collagen-induced activation of Syk and the subsequent phosphorylation of phospholipase Cγ2 in platelets. J Biol Chem. 271:1996;26668-26676.
18. Poole A, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JG, Saito T, Tybulewicz VL, Watson SP The Fc receptor γ-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 16:1997;2333-2341.
19. Barnes MJ, Knight CG, Farndale RW The collagen-platelet interaction. Curr Opin Hematol. 5:1998;314-320.
20. Kunapuli SP Functional characterization of platelet ADP. Platelets. 9:1998;343-351.
21. Jantzen HM, Gousset L, Bhaskar V, Vincent D, Tai A, Reynolds EE, Conley PB Evidence for two distinct G-protein-coupled ADP receptors mediating platelet activation. Thromb Haemost. 81:1999;111-117.
22. Fruman DA, Meyers RE, Cantley LC Phosphoinositide kinases. Annu Rev Biochem. 67:1998;481-507.
23. 3, as defined by acquiring the ability to binding large soluble ligands.
24. 3 signaling in platelets. Blood. 93:1999;2645-2652. Studies with platelets from Syk knockout mice demonstrate that Syk plays a significant but minor role in platelet aggregation induced by ADP (plus or minus epinephrine).
25. Saci A, Pain S, Rendu F, Bachelot-Loza C Fc receptor-mediated platelet activation is dependent on phosphatidylinositol 3-kinase activation and involves p120(Cbl). J Biol Chem. 274:1999;1898-1904. In this paper the significant contribution of PI3K to Fc receptor-induced platelet activation versus a minor contribution to thrombin-induced activation is noted. In addition, little was known of the role of the adapter protein Cbl in platelet function but here its coupling to the catalytic domain of PI3K and potential role in recruiting PI3K to the Fc receptor is described.
26. Banfic H, Downes CP, Rittenhouse SE Biphasic activation of PKBα/Akt in platelets. Evidence for stimulation both by phosphatidylinositol 3,4-bisphosphate, produced via a novel pathway, and by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 273:1998;11630-11637.
27. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J, Dedhar S Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA. 95:1998;11211-11216. Although platelets were not studied here, the observation that integrin linked kinase (ILK) activity is positioned between PI3K and PKB is a finding of potential significance to platelet function.
28. Zhang Z, Vuori K, Wang H, Reed JC, Ruoslahti E Integrin activation by R-ras. Cell. 85:1996;61-69.
29. Chaves-Olarte E, Low P, Freer E, Norlin T, Weidmann M, von Eichel-Streiber C, Thelestam M A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins. J Biol Chem. 274:1999;11046-11052. The identification by these authors of a cytotoxin that selectively inhibits R-Ras should prove useful in determining the role of R-Ras in platelet function.
30. Morii N, Teru-uchi T, Tominaga T, Kumagai N, Kozaki S, Ushikubi F, Narumiya S A rho gene product in human blood platelets. II. Effects of the ADP-ribosylation by botulinum C3 ADP-ribosyltransferase on platelet aggregation. J Biol Chem. 267:1992;20921-20926.
31. 3 activation, as had been previously reported. RhoA does contribute, however, to platelet adhesion and focal contact formation.
32. Hughes PE, Renshaw MW, Pfaff M, Forsyth J, Keivens VM, Schwartz MA, Ginsberg MH Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell. 88:1997;521-530.
33. McNicol A, Philpott CL, Shibou TS, Israels SJ Effects of the mitogen-activated protein (MAP) kinase kinase inhibitor 2-(2′-amino-3′-methoxyphenyl)-oxanaphthalen-4-one (PD98059) on human platelet activation. Biochem Pharmacol. 55:1998;1759-1767.
34. Shock DD, He K, Wencel-Drake JD, Parise LV Ras activation in platelets after stimulation of the thrombin receptor, thromboxane A2 receptor or protein kinase C. Biochem J. 321:1997;525-530.
35. 3 integrin function. PEA-15 is a member of the death effector domain (DED)-containing family of molecules, which were previously only known to function in apoptosis. PEA-15 mediates its rescue of integrin function through an R-Ras dependent pathway.
36. 3 activation is probably due to a conformational change of the integrin.
37. 3.
38. 3. A ternary complex of the integrin α and β subunits and a divalent cation. J Biol Chem. 271:1996;6017-6026.
39. IIb cytoplasmic domain. J Biol Chem. 272:1997;4651-4654.
40. Sarkar S, Rooney MM, Lord ST Activation of integrin-β3-associated Syk in platelets. Biochem J. 338:1999;677-680.
41. 3 in resting platelets. Biochem Mol Biol Int. 45:1998;735-743.
42. Farrell DH, Thiagarajan P, Chung DW, Davie EW Role of fibrinogen α and γ chain sites in platelet aggregation. Proc Natl Acad Sci USA. 89:1992;10729-10732.
43. 3 dependent process. These results suggest the presence in fibrin of an unknown platelet binding site that mediates clot retraction.
44. IIb.
45. 3 and its mechanism of attachment to the cytoskeleton.
46. 3 integrin cytoplasmic binding protein. Although the functional significance of this association in platelets is unknown, it might play a role in cell spreading.
47. Hemler ME Integrin associated proteins. Curr Opin Cell Biol. 10:1998;578-585.
48. 3 integrins in haemopoietic cell lines and modulates cell-cell adhesion. Biochem J. 338:1999;61-70.
49. 3-mediated pp125FAK phosphorylation and platelet spreading on fibrinogen are regulated by PI 3-kinase. Biochim Biophys Acta. 1448:1999;543-552.
50. Keely PJ, Westwick JK, Whitehead IP, Der CJ, Parise LV Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K. Nature. 390:1997;632-636.
51. Miranti CK, Leng L, Maschberger P, Brugge JS, Shattil SJ Identification of a novel integrin signaling pathway involving the kinase Syk and the guanine nucleotide exchange factor Vav1. Curr Biol. 8:1998;1289-1299. A unique outside-in signaling pathway is described, which is downstream of Syk and Vav and involves a number of kinases such as JNK, Erk2 and PKB, as well as the adapter protein, Cbl. The potential functional significance of these events in platelets is currently unknown.